India opened its doors to foreign companies that manufacture COVID-19 vaccines to come to India on April 13, 2021, those which have been approved for restricted use by US Food and Drug Administration (USFDA), European Medicines Agency (EMA), UK Medicines and Healthcare products Regulatory Agency (MHRA), Pharmaceuticals and Medical Devices Agency (PMDA) Japan or which are listed in the World Health Organisation (WHO)’s emergency use listing (EUL). Prior to this, India was using COVISHIELD manufactured by Serum Institute of India and COVAXIN manufactured by Bharat Biotech to vaccinate the citizens of the nation against COVID-19. On April 12, 2021, the Drug Controller General of India (DCGI) approved the Russian COVID-19 vaccine, Sputnik V, which became the first foreign vaccine to receive approval in India.
A tall order
As on May 31, 2021 the cumulative number of COVID-19 vaccine doses administered in India exceeded 21.58 crore. The total of 21,58,18,547 include 98,83,778 Healthcare Workers (HCWs) who have taken the 1st dose and 67,87,633 HCWs who have taken the 2nd dose, 1,56,67,311 Frontline Workers (FLWs) (1st dose), 85,21,965 FLWs (2nd dose), 2,02,10,889 for 18-44 years of age group (1st dose) and 23,491 for 18-44 years of age group (2nd dose). 6,64,02,012 for over 45 years old to 60 years old (1st Dose), 1,07,15,693 for over 45 years old to 60 years old (2nd dose), 5,88,31,736 for above 60 years (1st Dose) and 1,87,74,039 for above 60 years (2nd Dose).
This story is from the BioSpectrum Asia June 2021 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum Asia June 2021 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Ushering Fourth Industrial Revolution in Telangana
Taking advantage of the 21st edition of BioAsia 2024 at the Hyderabad International Convention Centre (HICC) in Madhapur, the Government of Telangana, a southern state in India, leveraged the confluence of the global platform to spearhead initiatives aimed at propelling the state into the forefront of the Fourth Industrial Revolution (C4IR).
How Indian Biotech Investments are on a Doubling Spree
A latest report by Ankur Capital provides a closer look at the investments made in biotechnology in the last decade in the country.
"AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option”
South Korea-based Deep Bio, a pioneering artificial intelligence (AI) healthcare firm focused on cancer pathology, is making waves in the industry.
"Because of its specificity and selectivity, ADCS have the potential to reduce adverse side effects and improve patient survival"
Japan-headquartered Daiichi Sankyo, the global healthcare company, launched its subsidiary Daiichi Sankyo Singapore Pte. Ltd. to bridge unmet needs in oncology.
Can Test, Treat, Track Beat Malaria?
Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people.
Engineering CAR T cell sharpshooters
Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers.
Addressing Challenges in Cell Therapy Manufacturing
Even with significant advancements, there are still anumber of issues with cell therapy manufacturing that need to be resolved as production grows.
"We anticipate India will adopt decentralised models for managing CGTs, ensuring closer proximity between patients and treatment facilities"
Cell and gene therapy (CGT) expert from Germany, Miltenyi Biotec has recently announced its entry into the Indian market to provide researchers, scientists and clinicians easier access to expertise, research, and manufacturing solutions.
Addressing Accessibility and Affordability of CELL & GENE THERAPIES
Cell and gene therapies (CGT) are one of the hottest sectors in the pharmaceutical industry.
Korea designs sweat resistant wearable robot sensor
New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.
